What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- The promise of precision medicine in rheumatology July 5, 2022
- Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals June 20, 2022
- Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus June 20, 2022
- 47XXY and 47XXX in Scleroderma and Myositis March 30, 2022
- A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies March 7, 2022
- Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus January 10, 2022
- Quantifying Chemical Composition and Reaction Kinetics of Individual Colloidally Dispersed Nanoparticles December 28, 2021